Metformin Use in Type 2 Diabetes Mellitus With CKD: Is It Time to Liberalize Dosing Recommendations?

被引:8
|
作者
Stanton, Robert C. [1 ]
机构
[1] Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02215 USA
关键词
LACTIC-ACIDOSIS; RENAL IMPAIRMENT; RISK;
D O I
10.1053/j.ajkd.2015.04.001
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:193 / 195
页数:3
相关论文
共 50 条
  • [31] Lactic acidosis induced by metformin in a chronic hemodialysis patient with diabetes mellitus type 2
    Altun, Eda
    Kaya, Bulent
    Paydas, Saime
    Sariakcali, Baris
    Karayaylali, Ibrahim
    HEMODIALYSIS INTERNATIONAL, 2014, 18 (02) : 529 - 531
  • [32] Metformin changes the immune microenvironment of colorectal cancer in patients with type 2 diabetes mellitus
    Saito, Akira
    Kitayama, Joji
    Horie, Hisanaga
    Koinuma, Koji
    Ohzawa, Hideyuki
    Yamaguchi, Hironori
    Kawahira, Hiroshi
    Mimura, Toshiki
    Lefor, Alan Kawarai
    Sata, Naohiro
    CANCER SCIENCE, 2020, 111 (11) : 4012 - 4020
  • [33] The Effect of Metformin on Oncological Outcomes in Patients With Cervical Cancer With Type 2 Diabetes Mellitus
    Hanprasertpong, Jitti
    Jiamset, Ingporn
    Geater, Alan
    Peerawong, Thanarpan
    Hemman, Wikanda
    Kornsilp, Sasima
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 (01) : 131 - 137
  • [34] Effects of metformin exposure on neurodegenerative diseases in elderly patients with type 2 diabetes mellitus
    Kuan, Yi-Chun
    Huang, Kuang-Wei
    Lin, Cheng-Li
    Hu, Chaur-Jong
    Kao, Chia-Hung
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2017, 79 : 77 - 83
  • [35] The Use of Metformin and the Incidence of Lung Cancer in Patients With Type 2 Diabetes
    Smiechowski, Brielan B.
    Azoulay, Laurent
    Yin, Hui
    Pollak, Michael N.
    Suissa, Samy
    DIABETES CARE, 2013, 36 (01) : 124 - 129
  • [36] Safety and Efficacy of Metformin in Patients With Type 2 Diabetes Mellitus and Chronic Hepatitis C
    Harris, Kira
    Smith, Lisa
    ANNALS OF PHARMACOTHERAPY, 2013, 47 (10) : 1348 - 1352
  • [37] The effects of rosiglitazone and metformin on inflammation and endothelial dysfunction in patients with type 2 diabetes mellitus
    Fidan, Evren
    Ersoz, H. Onder
    Yilmaz, Mustafa
    Yilmaz, Hulya
    Kocak, Mustafa
    Karahan, Caner
    Erem, Cihangir
    ACTA DIABETOLOGICA, 2011, 48 (04) : 297 - 302
  • [38] Efficacy and safety of metformin in the management of type 2 diabetes mellitus in older adults: a systematic review for the development of recommendations to reduce potentially inappropriate prescribing
    Schlender, Lisa
    Martinez, Yolanda V.
    Adeniji, Charles
    Reeves, David
    Faller, Barbara
    Sommerauer, Christina
    Al Qur'an, Thekraiat
    Woodham, Adrine
    Kunnamo, Ilkka
    Soennichsen, Andreas
    Renom-Guiteras, Anna
    BMC GERIATRICS, 2017, 17
  • [39] Effect of Metformin on C-reactive Protein in Type 2 Diabetes Mellitus Patients
    Selvi, P.
    Elizabeth, Arul Amutha
    JOURNAL OF PHARMACEUTICAL RESEARCH INTERNATIONAL, 2021, 33 (23B) : 53 - 61
  • [40] Association Between Metformin Use and Mortality among Patients with Type 2 Diabetes Mellitus Hospitalized for COVID-19 Infection
    Ong, Angeli Nicole
    Tan, Ceryl Cindy
    Canete, Maria Teresa
    Lim, Bryan Albert
    Robles, Jeremyjones
    JOURNAL OF THE ASEAN FEDERATION OF ENDOCRINE SOCIETIES, 2021, 36 (02): : 133 - 141